HEALTH CARE
- Share via
Four New Divisions: ICN Biomedicals Inc., a subsidiary of Costa Mesa-based drug conglomerate ICN Pharmaceuticals Inc., has just completed a restructuring.
The company, which manufactures and sells chemicals and instruments for medical research and development, has divided itself into four divisions for greater efficiency, said ICN spokesman Paul Knopick.
The new divisions are: diagnostics, which will oversee the manufacture and marketing of neonatal test kits and other diagnostics products; dosimetry, which oversees the company’s manufacture of radiation monitoring devices for X-ray laboratories, medical and dental offices and nuclear power plants; research products, which includes biochemical, organic chemical and cell products; and international sales.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
